Immunogenic potential of irradiated lymphoma cells is enhanced by adjuvant immunotherapy and modulation of local macrophage populations.
AffiliationTargeted Therapy Group, Institute of Cancer Sciences, University of Manchester, Manchester Academic Health Sciences Centre, Paterson Institute for Cancer Research, Manchester, UK.
MetadataShow full item record
AbstractThe aim of this study was to assess the immunogenic potential of irradiated lymphoma cells in vivo and determine whether immunogenicity can be enhanced by modulation of the host immune system. Syngeneic murine lymphoma models irradiated ex vivo were used as an orthotopic cellular vaccination prior to challenge with viable tumor cells. We demonstrate that irradiated lymphoma cells are poorly immunogenic and that protective anti-tumor CD8 T-cell responses require the addition of immunostimulatory monoclonal antibody as an immune adjuvant, and increased frequency of antigen exposure by multiple vaccinations. Furthermore, we show the potential importance of macrophages in regulating immunogenicity of irradiated lymphoma cells and demonstrate that depletion of macrophages using clodronate-encapsulated liposomes considerably enhances primary vaccination efficacy in the presence of adjuvant anti-CD40 antibody. Our results demonstrate that the immunogenic potential of poorly immunogenic lymphoma cells dying after radiation therapy can be improved by modulation of the host immune system.
CitationImmunogenic potential of irradiated lymphoma cells is enhanced by adjuvant immunotherapy and modulation of local macrophage populations. 2013, 54 (9):2008-15 Leuk Lymphoma
JournalLeukemia & Lymphoma
- Conjugation of lymphoma idiotype to CD40 antibody enhances lymphoma vaccine immunogenicity and antitumor effects in mice.
- Authors: Carlring J, Szabo MJ, Dickinson R, De Leenheer E, Heath AW
- Issue date: 2012 Mar 1
- In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models.
- Authors: Oba T, Makino K, Kajihara R, Yokoi T, Araki R, Abe M, Minderman H, Chang AE, Odunsi K, Ito F
- Issue date: 2021 May
- CD40 ligation in vivo can induce T cell independent antitumor effects even against immunogenic tumors.
- Authors: Rakhmilevich AL, Buhtoiarov IN, Malkovsky M, Sondel PM
- Issue date: 2008 Aug
- Three steps to breaking immune tolerance to lymphoma: a microparticle approach.
- Authors: Makkouk A, Joshi VB, Lemke CD, Wongrakpanich A, Olivier AK, Blackwell SE, Salem AK, Weiner GJ
- Issue date: 2015 Apr
- Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells.
- Authors: Liu K, Idoyaga J, Charalambous A, Fujii S, Bonito A, Mordoh J, Wainstok R, Bai XF, Liu Y, Steinman RM
- Issue date: 2005 Dec 5